calpain and 2-tert-butylhydroquinone

calpain has been researched along with 2-tert-butylhydroquinone* in 2 studies

Other Studies

2 other study(ies) available for calpain and 2-tert-butylhydroquinone

ArticleYear
Tertiary-butylhydroquinone upregulates expression of ATP-binding cassette transporter A1 via nuclear factor E2-related factor 2/heme oxygenase-1 signaling in THP-1 macrophage-derived foam cells.
    Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:9

    Tert-butylhydroquinone (tBHQ), a synthetic phenolic antioxidant, is commonly used as a food preservative because of its potent antilipid peroxidation activity. Several lines of evidence have demonstrated that dietary supplementation with antioxidants has an antiatherogenic function through reducing cholesterol uptake or promoting reverse cholesterol transport. In this study, we investigated whether tBHQ affects expression of ATP-binding cassette transporter A1 (ABCA1) and the potential subsequent effect on cellular cholesterol homeostasis.. tBHQ increased ABCA1 protein levels and markedly enhanced cholesterol efflux from THP-1 macrophage-derived foam cells. Furthermore, tBHQ reduced calpain-mediated ABCA1 proteolysis via activation of nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). Inhibition of HO-1 with a pharmacological inhibitor or siRNA and knockdown of Nrf2 suppressed the stimulatory effects of tBHQ on ABCA1 expression and calpain activity.. Nrf2/HO-1 signaling is required for the regulation by tBHQ of ABCA1 expression and cholesterol efflux in macrophage-derived foam cells and an antiatherogenic role of tBHQ is suggested.

    Topics: Antioxidants; ATP Binding Cassette Transporter 1; Calpain; Cell Line, Tumor; Foam Cells; Heme Oxygenase-1; Humans; Hydroquinones; NF-E2-Related Factor 2; Signal Transduction; Up-Regulation

2013
Ca(2+)-ATPase pump forms and an endogenous inhibitor in bovine brain synaptosomes.
    Neurochemical research, 1997, Volume: 22, Issue:3

    Two forms of Ca(2+)-pump were identified in bovine brain synaptic membranes as aspartylphosphate intermediates and were characterized. The 140 kDa and 97 kDa phosphoproteins were digested by calpain, producing two phosphorylated fragments, of M.W. 124 and 80 kDa respectively, not inhibited by thapsigargin, and displayed a trypsin digestion pattern with the formation of one phosphorylatable fragment of about 80 kDa. These results suggest that both pumps belong to the Plasma Membrane-type of Ca2+ ATPases, differing from the Sarco- or Endoplasmic Reticulum kind. A plasma membrane Ca(2+)-ATPase proteinaceous inhibitor with molecular weight between 6,000 and 10,000 Da was resolved from synaptic terminal cytosol, where it is enriched by fourfold with respect to frontal cortex brain cytosol. Such enrichment is already evident in the correspondent crude fractions. The presence of calcium pump and its proteinaceous inhibitor inside the synaptic terminals from bovine brain is discussed in terms of free calcium level regulation in neuron synaptoplasm.

    Topics: Animals; Antioxidants; Calcium-Transporting ATPases; Calpain; Cattle; Cytosol; Enzyme Inhibitors; Hydroquinones; Membrane Proteins; Molecular Weight; Phosphorylation; Prefrontal Cortex; Synaptic Membranes; Synaptosomes; Thapsigargin; Trypsin

1997